Back to search
Oligodendroglioma; Oligoastrocytoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Oligodendroglioma; Oligoastrocytoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Oligodendroglioma; Oligoastrocytoma trials you may qualify forThis is an open-label, multi-center, Phase 1/2 study of the brain-penetrant MEK inhibitor, mirdametinib (PD-0325901), in patients with pediatric low-grade gliom…
This phase II trial studies how well temozolomide and radiation therapy work in treating patients with IDH wildtype historically lower grade gliomas or non-hist…
This randomized phase II clinical trial studies the side effects and how well proton beam or intensity-modulated radiation therapy works in preserving brain fun…
The first-line treatment of anaplastic oligodendrogliomas, radiotherapy exclusive or combined with PCV, will be defined by the pending results of phase III of t…